购物车
- 全部删除
- 您的购物车当前为空
NU6300 is an inhibitor of the first covalent ATP-competitive CDK2.
为众多的药物研发团队赋能,
让新药发现更简单!
NU6300 is an inhibitor of the first covalent ATP-competitive CDK2.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | 询价 | 5日内发货 | |
5 mg | ¥ 7,450 | 5日内发货 | |
25 mg | ¥ 12,650 | 8-10周 | |
50 mg | ¥ 16,400 | 8-10周 | |
100 mg | ¥ 21,000 | 8-10周 | |
1 mL x 10 mM (in DMSO) | ¥ 8,250 | 5日内发货 |
产品描述 | NU6300 is an inhibitor of the first covalent ATP-competitive CDK2. |
靶点活性 | CDK2:0.16 μM |
体外活性 | NU6300 blocks the inhibitor binding site. The effect was time-dependent and relatively slow, with less than 50% reduction of the apparent binding capacity in 20 hr. NU6300 is a covalent CDK2 inhibitor that illustrates the potential of using vinyl sulfones to mediate irreversible inhibition. |
分子量 | 413.49 |
分子式 | C20H23N5O3S |
CAS No. | 2070015-09-5 |
密度 | 1.344 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 32 mg/mL (77.39 mM) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容